文献速递生殖医学

辅助生殖技术中的个性化卵巢刺激:研究设计考量——从炒作到为患者带来附加价值

Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients.
PubMed 文献 · Fertil Steril · 2018-01-01

本文综述辅助生殖技术治疗中可个性化的环节,强调需通过随机试验比较个性化与一刀切策略的结局和安全性,并提出可仅招募个性化方案与标准方案存在差异患者的靶向随机设计,以及多中心同方案研究以减少中心效应,部分情况下单臂观察性研究可提供必要证据。

要点

  • 个性化生殖医学尚处起步阶段,缺乏明确指导。
  • 个性化方案优越性需随机试验比较个性化与一刀切策略。
  • 靶向随机设计可仅招募个性化与标准方案有差异的患者。

核心结论

  • 个性化卵巢刺激的优越性证据需来自比较个性化与一刀切策略结局和安全性的随机试验。

研究设计与样本

  • 本综述描述辅助生殖技术治疗各主要环节,讨论可个性化方面、当前证据及相关研究设计。

主要发现

  • 个性化方案的理论依据常基于大型观察性研究或真实世界数据的回顾性分析。
  • 采用相同研究方案的多中心研究可能减少多中心研究相关的中心效应。
  • 某些情况下单臂观察性研究可产生个性化方案所需证据。

局限性

  • 个性化生殖医学仍处起步阶段,缺乏对可个性化治疗方面及评估个性化治疗效应与获益-风险平衡的试验设计的明确指导。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although most medical treatments are designed for the average patient with a one-size-fits-all-approach, they may not benefit all. Better understanding of the function of genes, proteins, and metabolite, and of personal and environmental factors has led to a call for personalized medicine. Personalized reproductive medicine is still in its infancy, without clear guidance on treatment aspects that could be personalized and on trial design to evaluate personalized treatment effect and benefit-harm balance. While the rationale for a personalized approach often relies on retrospective analyses of large observational studies or real-world data, solid evidence of superiority of a personalized approach will come from randomized trials comparing outcomes and safety between a personalized and one-size-fits-all strategy. A more efficient, targeted randomized trial design may recruit only patients or couples for which the personalized approach would differ from the previous, standard approach. Multiple monocenter studies using the same study protocol (allowing future meta-analysis) might reduce the major center effect associated with multicenter studies. In certain cases, single-arm observational studies can generate the necessary evidence for a personalized approach. This review describes each of the main segments of patient care in assisted reproductive technologies treatment, addressing which aspects could be personalized, emphasizing current evidence and relevant study design.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Mol BW, Bossuyt PM, Sunkara SK, et al. Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients. Fertil Steril. 2018. PMID: 29935655. doi:10.1016/j.fertnstert.2018.04.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。